In the cellular ferroptosis defense mechanism, GPX4 and SLC7A11 indeed play important roles, especially in malignant tumors where aberrant expression or function of GPX4 and SLC7A11 often accompanies and affects the susceptibility of cancer cells to ferroptosis. The gene discussed is GPX4; the disease is cancer.